Met Life Investment Management, LLC Iovance Biotherapeutics, Inc. Transaction History
Met Life Investment Management, LLC
- $16.5 Billion
- Q2 2025
A detailed history of Met Life Investment Management, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 150,974 shares of IOVA stock, worth $339,691. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150,974
Previous 151,206
0.15%
Holding current value
$339,691
Previous $503,000
48.51%
% of portfolio
0.0%
Previous 0.0%
Shares
40 transactions
Others Institutions Holding IOVA
# of Institutions
286Shares Held
233MCall Options Held
1.12MPut Options Held
1.15M-
Mhr Fund Management LLC New York, NY29MShares$65.2 Million8.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA25.1MShares$56.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$47.8 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR11.8MShares$26.6 Million0.94% of portfolio
-
State Street Corp Boston, MA9.89MShares$22.3 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $355M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...